Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Improving glycaemic control with current therapies

K I Birkeland1

  • 1Hormone Laboratory and Aker Diabetes Research Centre, Aker University Hospital, Oslo, Norway.

Diabetic Medicine : a Journal of the British Diabetic Association
|December 30, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epigenome-wide association study of DNA methylation in maternal blood leukocytes with BMI in pregnancy and gestational weight gain.

International journal of obesity (2005)·2024
Same author

Higher frequency of hospitalization but lower relative mortality for pandemic influenza in people with type 2 diabetes.

Journal of internal medicine·2019
Same author

Diabetes prevalence among older people receiving care at home: associations with symptoms, health status and psychological well-being.

Diabetic medicine : a journal of the British Diabetic Association·2018
Same author

Global mRNA sequencing of human skeletal muscle: Search for novel exercise-regulated myokines.

Molecular metabolism·2017
Same author

Myostatin in relation to physical activity and dysglycaemia and its effect on energy metabolism in human skeletal muscle cells.

Acta physiologica (Oxford, England)·2015
Same author

The exercise-regulated myokine chitinase-3-like protein 1 stimulates human myocyte proliferation.

Acta physiologica (Oxford, England)·2015
Same journal

Refining metabolic-response signals after liraglutide therapy in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Finger-stick glucose testing as an institutional stressor: Staff perspectives from long-term care.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Prevalence, duration, and clinical implications of continuous glucose monitor measurement limit capping in type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Disentangling the effect of brain insulin resistance on brain health (BIR-BrainHealth): Rationale and study protocol.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Clinical characteristics and in-hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open-loop era: A UK-wide MINAP registry analysis.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same journal

Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?

Diabetic medicine : a journal of the British Diabetic Association·2026
See all related articles

Optimizing Type 2 diabetes treatment requires personalized strategies beyond traditional approaches. Tailored insulin therapy, potentially combined with oral agents like metformin, shows promise for improving glycaemic control and quality of life.

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Pharmacotherapy

Background:

  • Type 2 diabetes (T2D) is characterized by hyperglycaemia, leading to reduced quality of life and increased risk of complications.
  • Current treatment approaches often fail to keep pace with disease progression, necessitating novel therapeutic strategies.
  • T2D is a heterogeneous condition involving insulin deficiency and resistance, with a natural progression towards worsening hyperglycaemia.

Purpose of the Study:

  • To explore advanced therapeutic strategies for Type 2 diabetes management.
  • To address the limitations of traditional stepped-care approaches in achieving optimal glycaemic control.
  • To highlight the importance of personalized treatment tailored to individual patient needs.

Main Methods:

  • Review of existing literature on Type 2 diabetes pharmacotherapy, including oral hypoglycaemic agents (OHAs) and insulin therapy.

Related Experiment Videos

  • Analysis of treatment effectiveness based on patient's insulin secretory capacity and disease progression.
  • Consideration of combination therapies, including OHAs with insulin, and patient self-management.

    • Main Results:

    • Oral hypoglycaemic agents are less effective in patients with significant beta-cell failure.
    • Insulin therapy can improve glycaemic control and quality of life, but achieving near-normoglycaemia presents challenges.
    • Combination therapy, such as bedtime insulin with daytime metformin, may offer superior outcomes for certain patient groups.

    Conclusions:

    • Personalized therapy, including tailored insulin regimens and patient education for self-adjustment, is crucial for effective Type 2 diabetes management.
    • Combination therapies, particularly insulin and oral agents, warrant further investigation for optimizing treatment outcomes.
    • Continued research is needed to develop optimal therapeutic strategies for the heterogeneous nature of Type 2 diabetes.